Loadingβ¦

The hardest part of patent monetization is not the law or the paperwork. It is finding the specific companies with a concrete reason to pay β and reaching the people inside them who can say yes. Patents are not listed on an exchange; every deal starts with somebody building a list and making contact.
This guide covers that work: who actually buys and licenses patents, how to build a realistic target list, and how to run outreach that produces negotiations instead of silence. It pairs with our guides on patent valuation (know your number first) and how to license a patent (what happens once someone engages).
Operating companies in your space. Manufacturers and brands that make, or want to make, products your claims cover. They license to clear risk, to gain an edge, or to add your invention to their line. This is where most realistic deals live.
Competitors of current users. If Company A is practicing your invention, Companies B and C have two reasons to engage: to license the advantage themselves, or to acquire the patent and reset the competitive board.
Licensing and assertion firms. Businesses that acquire or partner on patents specifically to run enforcement-backed licensing campaigns. They evaluate hard β strong evidence of use is the ticket in β and deals are usually revenue shares or discounted cash purchases.
Defensive buyers and aggregators. Large technology companies and consortiums acquire patents to reduce their own exposure. Relevant mainly for portfolios reading on big-company products.
Suppliers and adjacent players. Companies one step up or down the value chain β a component maker whose customers would need your license, a distributor wanting an exclusive product angle.
Notice who is missing: "investors" in the abstract. People rarely buy patents as passive assets. Every real buyer has an operational reason, and your target list should be built around those reasons.
The productive method works backward from the market:
A serious campaign usually enters outreach with 25β100 ranked targets. Fewer means the search was shallow; more usually means the ranking discipline slipped.
Targets engage with evidence, not adjectives. Before the first email, prepare:
This package is 80% of the difference between campaigns that get meetings and campaigns that get silence.
Titles that engage with patent opportunities, roughly in order: VP/Director of Product or Engineering (they understand the technology fastest), Corporate/Business Development, in-house IP Counsel, and in smaller companies the CEO directly. General counsel and "info@" inboxes are where cold patent letters go to die.
The outreach that works is short, specific, and commercial: two or three sentences on what your patent covers, one on the evidence ("attached is a summary showing coverage of products in your category"), and a clear ask for a 20-minute call. No legal threats, no 40-page attachments, no exclamation points. Follow up politely on a schedule; most responses come from the second or third touch.
A caution on active infringers. The strongest targets β companies already practicing your claims β are also the most delicate. First contact framed as accusation can trigger a declaratory-judgment filing that drags you into court on their terms and timeline. Approaches to likely infringers should be planned with professional advice on wording, sequence, and venue exposure.
Treat outreach as a pipeline with stages β contacted, responded, under NDA, evaluating, negotiating β and manage it weekly. Realistic conversion expectations: a well-built 50-target list might produce 10β15 responses, 4β6 genuine evaluations, and 1β3 negotiations. Each evaluation takes weeks (engineering review) to months (legal and budget). The campaigns that fail usually die of impatience or of a target list built on hope instead of motive.
Parallel matters too: interest from one company is your leverage with the others. "We are in discussions with another party in your market" is the sentence that moves corporate timelines β but only when it is true, which is one more argument for running the list broadly rather than serially.
Run it yourself when your niche is small, you know the players personally, and the realistic outcome is a modest license you can negotiate directly.
Bring in a broker or licensing firm when the targets are corporations with process, when evidence needs professional claim charting, or when the outcome justifies sharing it. Good firms bring three things you cannot shortcut: existing relationships with the people who take these meetings, pattern recognition on what each industry pays, and the credibility that comes from a counterparty they have dealt with before.
This campaign work β target research, evidence packages, outreach, and negotiation β is the core of ILG's patent licensing service. We build target lists from the product market up and run the process through to signed agreements. If you want a realistic read on who would pay for your patent and why, schedule a consultation β and avoid the mistakes that sink most monetization efforts before they start.
Five main groups: operating companies that practice (or want to block others from practicing) the technology, competitors of companies already using it, patent licensing and assertion firms that monetize through enforcement, defensive buyers and aggregators that acquire to reduce litigation risk, and occasionally investors or funds that treat IP as an asset class. Operating companies in your technology space are usually the most realistic starting point.
Start from the products, not the companies: list products on the market that appear to practice your claims, then identify who makes them, who supplies them, and who competes with them. Forward and backward citations on your patent, trade-show exhibitor lists, and industry distributor catalogs expand the list. A well-built target list usually has 25β100 names before outreach begins.
Companies already using your technology are your strongest prospects β they have proven the market and have exposure β but approach them carefully. The framing of the first contact (licensing opportunity vs. accusation) shapes everything after, and in some situations a demand letter can trigger the recipient to file for declaratory judgment in their preferred court. Get professional advice before approaching an active infringer.
From organized outreach to a signed agreement, 6β18 months is typical. Corporate licensing decisions pass through engineering review, legal review, and budget cycles, each adding weeks or months. Processes shorter than that usually involve a buyer who was already looking; longer ones usually mean the target list or the evidence needs rework.
Yes β inventors close direct deals, especially in niches where they know the players personally. The trade-off is time and reach: brokers and licensing firms bring existing relationships, evidence-building experience, and negotiating depth in exchange for a commission, commonly 20β35% of the outcome. The math favors going alone only when you can genuinely reach the decision-makers yourself.
Talk through your situation with our team β no cost, no obligation.
Our team is happy to talk through your situation and explore your options.
Most patents sell for far less than their owners hope β and a few sell for far more. Here is how buyers, licensees, and courts actually put a number on a patent, and how to estimate yours honestly.
7 min read
Patent MonetizationLearn the complete patent sale process from valuation to closing. Expert insights on pricing, finding buyers, negotiating deals, and avoiding common pitfalls.
15 min read
Patent MonetizationLearn how to license a patent from valuation to negotiation. Master licensing structures, terms, and strategies to maximize your patent revenue.
12 min read